GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Suzuken Co Ltd (TSE:9987) » Definitions » Capex-to-Revenue

Suzuken Co (TSE:9987) Capex-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Suzuken Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Suzuken Co's Capital Expenditure for the three months ended in Dec. 2023 was 円0.00 Mil. Its Revenue for the three months ended in Dec. 2023 was 円619,850.00 Mil.

Hence, Suzuken Co's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.00.


Suzuken Co Capex-to-Revenue Historical Data

The historical data trend for Suzuken Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzuken Co Capex-to-Revenue Chart

Suzuken Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 - 0.01 0.01 0.01

Suzuken Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Suzuken Co's Capex-to-Revenue

For the Medical Distribution subindustry, Suzuken Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzuken Co's Capex-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Suzuken Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Suzuken Co's Capex-to-Revenue falls into.



Suzuken Co Capex-to-Revenue Calculation

Suzuken Co's Capex-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-15640) / 2386493
=0.01

Suzuken Co's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (0) / 619850
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzuken Co  (TSE:9987) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Suzuken Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Suzuken Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzuken Co (TSE:9987) Business Description

Traded in Other Exchanges
N/A
Address
8 Higashi Kataha-machi, Higashi-ku, Nagoya, JPN, 461-8701
Suzuken Co Ltd is a Japanese drug manufacturer. It functions through four segments: Pharmaceutical Wholesale, which sells pharmaceuticals, diagnostic drugs, and medical equipment and materials; The Pharmaceutical Manufacturing, which produces pharmaceuticals and diagnostic drugs; The Insurance Pharmacy dispenses operations based on prescriptions from medical institutions and the Medical-related Service and Others segment which sells medical books, provides nursing services and manufactures physiological examination equipment.

Suzuken Co (TSE:9987) Headlines

No Headlines